This website has been developed by Besins Healthcare (UK) Ltd.

This website has separate sections for healthcare professionals (containing promotional information), and patients who have been prescribed Testogel® (testosterone) 16.2 mg/g gel, within the UK.

Please confirm that:

This website is provided for HCPs in the UK by Besins Healthcare (UK) Ltd.

Managing Patients

Managing Patients

Printable materials for patients

Download the Testogel® 16.2 mg/g gel Patient Package Leaflet.


Support patient self-management with the T Track app

Encourage your patients to download the T Tack app to track their own symptoms and progress, as well as get all the information they need on their Testogel® 16.2mg/g gel treatment.

T Track app available for both iOS and Android phones.

Support patient self-management with the T Track app

Request patient materials


    *Required field

    Besins Healthcare (UK) Ltd would like to request your consent for the company to use your email address to send information to you on the subject areas listed below. Please indicate your consent preference below.

    I agree to receiving information by email on the following topics:

    For example, an appointment request from a key account manager, information about the safety and effectiveness of our medicines, educational support for healthcare professionals and patients associated with our products.

    For example, educational events on the management of conditions associated with our medicine

    By clicking any of the above, you agree to Besins Healthcare terms of service and privacy policy.

    If you wish to amend or remove the consent you have selected above in the future, please email

    TES/2020/009. April 2021.

    Adverse event reporting

    Adverse events should be reported. Reporting forms and information can be found at or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: